These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 889420)

  • 21. Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine.
    Eap CB; Souche A; Koeb L; Baumann P
    Ther Drug Monit; 1991 Jul; 13(4):356-62. PubMed ID: 1780970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients.
    Dorado P; Berecz R; Peñas-Lledó EM; de la Rubia A; Llerena A
    Eur J Clin Pharmacol; 2007 May; 63(5):527-8. PubMed ID: 17345072
    [No Abstract]   [Full Text] [Related]  

  • 23. Complete heart block and torsade de pointes associated with thioridazine poisoning.
    Hulisz DT; Dasa SL; Black LD; Heiselman DE
    Pharmacotherapy; 1994; 14(2):239-45. PubMed ID: 8197047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors.
    Niedzwiecki DM; Mailman RB; Cubeddu LX
    J Pharmacol Exp Ther; 1984 Mar; 228(3):636-9. PubMed ID: 6707914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrocardiogram and cardiovascular changes in thioridazine and chlorpromazine poisoning.
    Strachan EM; Kelly CA; Bateman DN
    Eur J Clin Pharmacol; 2004 Oct; 60(8):541-5. PubMed ID: 15372128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations.
    Greendyke RM; Kanter DR
    J Clin Psychopharmacol; 1987 Jun; 7(3):178-82. PubMed ID: 3597804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of anticonvulsants on plasma haloperidol and thioridazine levels.
    Linnoila M; Viukari M; Vaisanen K; Auvinen J
    Am J Psychiatry; 1980 Jul; 137(7):819-21. PubMed ID: 6770696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot of plasma thioridazine and metabolites in chronically treated patients.
    Papadopoulos AS; Chand TG; Crammer JL; Lader S
    Br J Psychiatry; 1980 Jun; 136():591-6. PubMed ID: 7388266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous assay of thioridazine and its major metabolites in plasma at single dosage levels with a novel report of two ring sulfoxides of thioridazine.
    Wells CE; Juenge EC; Furman WB
    J Pharm Sci; 1983 Jun; 72(6):622-5. PubMed ID: 6875822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled double-blind study of haloperidol versus thioridazine in the treatment of restless mentally subnormal patients. Serum levels and clinical effects.
    Väisänen K; Rimón R; Räisänen P; Viukari M
    Acta Psychiatr Belg; 1979; 79(6):673-85. PubMed ID: 554446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: a dose proportionality study.
    Chakraborty BS; Midha KK; McKay G; Hawes EM; Hubbard JW; Korchinski ED; Choc MG; Robinson WT
    J Pharm Sci; 1989 Oct; 78(10):796-801. PubMed ID: 2600782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The assay of plasma concentration of thioridazine and its metabolites as a function of time.
    Gottschalk LA; Dinovo EC; Nandi BR
    Commun Psychopharmacol; 1978; 2(6):475-9. PubMed ID: 747914
    [No Abstract]   [Full Text] [Related]  

  • 33. Radioreceptor assay and high-performance liquid chromatography yield similar results for serum thioridazine and its major metabolites.
    Rao ML; Brown WA; Wagner R
    Ther Drug Monit; 1988; 10(2):184-7. PubMed ID: 3381236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of thioridazine and some of its metabolites to human serum protein and human albumin.
    Belpaire FM; Vanderheeren FA; Bogaert MG
    Arzneimittelforschung; 1975; 25(12):1969-71. PubMed ID: 1243669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. About a non-fatal massive intoxication with sustained-release thioridazine. Clinical and therapeutic problems.
    Buysschaert M; Mahieu P; Hassoun A; Col J; Reynaert M; Tremouroux J
    Acta Pharmacol Toxicol (Copenh); 1977; 41 Suppl 2():153-62. PubMed ID: 302559
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
    Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
    Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of thioridazine on gap junction intercellular communication in connexin 43-expressing cells.
    Matesic DF; Abifadel DN; Garcia EL; Jann MW
    Cell Biol Toxicol; 2006 Jul; 22(4):257-68. PubMed ID: 16685461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of the enantiomers of thioridazine, thioridazine 2-sulfoxide, thioridazine 2-sulfone, and thioridazine 5-sulfoxide in poor and extensive metabolizers of dextromethorphan and mephenytoin.
    Eap CB; Guentert TW; Schãublin-Loidl M; Stabl M; Koeb L; Powell K; Baumann P
    Clin Pharmacol Ther; 1996 Mar; 59(3):322-31. PubMed ID: 8653995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case report. Torsades de pointes caused by overdose of thioridazine].
    Näsh O; Rydenhag A
    Lakartidningen; 1993 Oct; 90(42):3677-8, 3681. PubMed ID: 8231516
    [No Abstract]   [Full Text] [Related]  

  • 40. GLC analysis of thioridazine, mesoridazine, and their metabolites.
    Dinovo EC; Gottschalk LA; Nandi BR; Geddes PG
    J Pharm Sci; 1976 May; 65(5):667-9. PubMed ID: 932933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.